Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:08:21.908Z.
Calculation as of: 2026-10-06T19:08:21.908Z.
Quote observation: 2026-10-06T19:04:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7871b69def0d47a4b8e1e85f1ab3a71b19ef0e5405565481473c56f3e01c6ed1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
60 Degrees Pharmaceuticals, Inc.
Market Cap
$3.83M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | $3.83M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.71M | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.96M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.74M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.70M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.60M | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.11M | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.54M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.56M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
